C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/02/2006	WO2006074389A3 Four-helical bundle protein zsig99
11/02/2006	WO2006074292A3 Target validation assay
11/02/2006	WO2006067254A3 Method and device for the in vitro diagnosis of familial hypercholesterolemia, based on the detection of mutations in the gene sequence of the low-density lipoprotein receptor (ldlr)
11/02/2006	WO2006066969A3 Sugarcane plants with an increased storage carbohydrate content
11/02/2006	WO2006062882A3 Protein-protein interaction detection system using fluorescent protein microdomains
11/02/2006	WO2006043178A3 Enzymes
11/02/2006	WO2006040357A3 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/02/2006	WO2006036975A3 Methods of embryo transfer
11/02/2006	WO2006034348A3 Enhanced antisense oligonucleotides
11/02/2006	WO2006031467A3 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
11/02/2006	WO2006030325A3 Method for identifying antimicrobial molecules which interfere with apoliporotein n-acyltransferase activity
11/02/2006	WO2006025718A3 Immunogen and antivenom against violin spider venom
11/02/2006	WO2005100590B1 Cell display libraries
11/02/2006	WO2005095442A8 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
11/02/2006	WO2005072262A3 Methods and compositions for evolving microbial hydrogen production
11/02/2006	WO2005067512A3 Novel carotenoid hydroxylases for use in engineering carotenoid metabolism in plants
11/02/2006	WO2004096996A3 Modulation of glucagon receptor expression
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248617 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
11/02/2006	US20060248616 Gene expression and production of TGF-beta proteins including bioactive mullerian inhibiting substance from plants
11/02/2006	US20060248615 Synthetic spider silk proteins and expression thereof in transgenic plants
11/02/2006	US20060248614 Implementation of a mitochondrial mutator
11/02/2006	US20060248613 Implementation of a mitochondrial mutator
11/02/2006	US20060248612 modulating properties of fruit dehiscence in plants, particularly Brassicaceae plants, specifically improving means for reducing seed shattering, or reducing seed shattering until after harvest, in plants, particularly the Brassicaceae plants grown for oil production
11/02/2006	US20060248611 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
11/02/2006	US20060248610 Fungus resistant plants and their uses
11/02/2006	US20060248609 DNAs coding for flavone synthases, methods of using flavone synthase DNAs, and plants, flowers, and vectors containing flavone synthase DNAs
11/02/2006	US20060248608 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained
11/02/2006	US20060248607 CCR6 chemokine receptor disruptions, compositions and methods relating thereto
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248604 Adeno-associated virus-delivered ribozyme compositions and methods of use
11/02/2006	US20060248602 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247429 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
11/02/2006	US20060247428 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
11/02/2006	US20060247421 Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same
11/02/2006	US20060247202 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247197 Method for down-regulating gene expression in fungi
11/02/2006	US20060247193 Regulation of gene expression by dna interference
11/02/2006	US20060247192 Control of apoptosis
11/02/2006	US20060247191 Chimeric cytoplasmic signalling molecules
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247164 Meltrins
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246590 Method of altering levels of plasmids
11/02/2006	US20060246589 Disintegrin and metalloproteinase containing thrombospondin 1-like domains (ADAMTS); ADAMTS13 protease and to nucleic acids encoding ADAMTS13 proteases; von Willebrand bactor cleaving protease activity; treating acquired thrombotic thrombocytopenic purpura; anticoagulant drug development
11/02/2006	US20060246588 Modified zinc finger binding proteins
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246586 Chromosome-based platforms
11/02/2006	US20060246585 Nucleic acid complex and method of introducing nucleic acid into cell using the same
11/02/2006	US20060246573 Bio-chip
11/02/2006	US20060246572 Automatic electroporation optimization system
11/02/2006	US20060246571 Apparatus and method for automatically producing substance-introduced particles
11/02/2006	US20060246569 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/02/2006	US20060246568 Cytidine deaminase
11/02/2006	US20060246567 Modified zinc finger binding proteins
11/02/2006	US20060246562 A recombinant E. coli strain transformed with a copy of an exogenous gene encoding an enzyme having a glycerol dehydratase activity, exogenous genes encoding a protein having a 1,3-propanediol oxidoreductase, cob(I)alamin adenosyltransferase, glycerol dehydratase activity
11/02/2006	US20060246561 Adh from rhodococcus erythropolis
11/02/2006	US20060246560 Compositions and methods for manipulating carbon flux in cells
11/02/2006	US20060246559 Method for the production of p-hydroxybenzoate in species of Pseudomonas and agrobacterium
11/02/2006	US20060246556 Novel method for the production of polyunsaturated fatty acids
11/02/2006	US20060246553 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids
11/02/2006	US20060246552 Novel plasmid autonomously replicable in enterobacteriaceae family
11/02/2006	US20060246550 Construction of antibody using mrl/lpr mouse
11/02/2006	US20060246549 Peptide acceptor ligation methods
11/02/2006	US20060246547 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/02/2006	US20060246545 Gene inactivated mutants with altered protein production
11/02/2006	US20060246542 System for antibody expression and assembly
11/02/2006	US20060246541 eukaryotic proteins that require formation of disulfide bridges for biological activity; comprising a thioredoxin located N-terminal to the domain
11/02/2006	US20060246539 Protein production method utilizing yebF
11/02/2006	US20060246519 For use in the capture and/or purification of biotinylated proteins
11/02/2006	US20060246515 High throughput generation and affinity maturation of humanized antibody
11/02/2006	US20060246509 Unnatural reactive amino acid genetic code additions
11/02/2006	US20060246504 Detection and treatment of polycystic kidney disease
11/02/2006	US20060246503 Genotyping nucleic acid sequences after immobilization onto solid supports; forensics; detection of trace amounts of nucleic acids
11/02/2006	US20060246491 Micro-RNA's that regulate muscle cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246471 Compositions and methods for screening pro-apoptotic compounds
11/02/2006	US20060246468 enzyme inhibitors; useful in the production of carbohydrate chains within glycoproteins/glycolipids; detecting, or inhibiting the production of, the alpha -1,3-fucosyltransferase which involves the use of cDNA coding the enzyme
11/02/2006	US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2006	US20060246462 Compositions for DNA amplification, synthesis, and mutagenesis
11/02/2006	US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer
11/02/2006	US20060246455 Method of diagnosing cancer and method of judging cancer risk
11/02/2006	US20060246453 Method of synthesizing cdna
11/02/2006	US20060246450 Ligational encoding of small molecules
11/02/2006	US20060246447 Method for detecting chlamydia trachomatis and kit therefor
11/02/2006	US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
11/02/2006	US20060246436 Method for judging sensibility to imatinib
11/02/2006	US20060246434 Nucleic acid amplification
11/02/2006	US20060246433 Method and nucleic acids for the analysis of a colon cell proliferative disorder
11/02/2006	US20060246432 Methods and materials for modulating task-3
11/02/2006	US20060246428 Polynucleotide probe and primer derived from hepatitis E virus recovered from japanese, chip including the same, kit including the same, and method of detecting hepatitis E virus genome using the same
11/02/2006	US20060246425 Infecting cells (serum free media), monitoring viability using flow cytometry open reading frame expression with flourescent antibody cell sorting; Postweaning multisystemic wasting syndrome; rapid, high yield
11/02/2006	US20060246424 Self-replicating RNA molecule from hepatitis C virus
11/02/2006	US20060246422 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11/02/2006	US20060246421 Compounds and methods for inhibiting hepatitis C virus replication
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246123 Oligonucleotide mimetics

1 ... 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 ... 4023